Has Johanna Lee received payments from drug or device companies?

Yes. Drug and device makers reported $8,727 in general payments to Johanna Lee across 221 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Johanna Lee did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Johanna Lee come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Johanna Lee

Family · Reno, NVNPI 1245962869

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 98.1% of the total across 221 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 53 manufacturers reported payments, led by Exelixis Inc. at 34.4% of the total. Reporting peaked in 2023 at $4,807 and has fallen 61.3% since, to $1,858 in 2025. Among family clinicians in NV with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$8,727in general payments, 2019–2025

Across 221 payments — averaging $39.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Exelixis Inc.$3K
E.r. Squibb & Sons, L.L.C.$384
AstraZeneca$345
Incyte Corporation$321
Johnson & Johnson$293
AbbVie$249
plus $4K from 47 others

What the payments were for

Food & beverage$8,55898%
Education$1692%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Exelixis Inc.	2	$3,004
E.r. Squibb & Sons, L.L.C.	14	$384
AstraZeneca(2 entities)	16	$345
Incyte Corporation	14	$321
Johnson & Johnson	11	$293
AbbVie	15	$249
Pfizer	11	$234
Ipsen Biopharmaceuticals, Inc	5	$226
Novartis	9	$223
Seagen Inc.	7	$217
Sanofi	4	$215
Spectrum Pharmaceuticals Inc.	3	$209
Merck	8	$206
Eisai Inc.	6	$173
Genentech USA, Inc.	7	$166
Regeneron Healthcare Solutions, Inc.	6	$163
GSK	6	$160
Sobi, Inc	5	$154
Deciphera Pharmaceuticals Inc.	5	$141
Tersera Therapeutics LLC	4	$123
Astellas Pharma US Inc	4	$97
Stemline Therapeutics Inc.	3	$95
Gilead(2 entities)	2	$94
Springworks Therapeutics, Inc.	3	$90
Takeda Pharmaceuticals U.S.A., Inc.	3	$86
Daiichi Sankyo Inc.	4	$85
Kyowa Kirin, Inc.	3	$79
Acrotech Biopharma Inc.	4	$78
Jazz Pharmaceuticals Inc.	4	$70
Amgen	2	$59
Servier Pharmaceuticals LLC	3	$56
Octapharma USA, Inc.	3	$53
Mirati Therapeutics, Inc.	2	$50
Lilly USA, LLC	2	$46
EMD Serono, Inc.	2	$44
Morphosys, US Inc.	2	$39
AVEO Pharmaceuticals, Inc.	1	$30
Beigene USA, Inc.	1	$29
Syndax Pharmaceuticals, Inc.	1	$28
Verity Pharmaceuticals Inc.	1	$28
Pharmaessentia USA Corporation	1	$28
Taiho Oncology, Inc.	1	$28
Genmab U.S., Inc.	1	$26
ADC Therapeutics America, Inc.	1	$25
Apellis Pharmaceuticals, Inc.	1	$25
Sun Pharmaceutical Industries Inc.	1	$24
Array Biopharma Inc	1	$24
Bristol Myers Squibb	1	$22
Agios Pharmaceuticals, Inc.	1	$22
Oyster Point Pharma, Inc.	1	$17
Bayer	1	$16
Pharmacyclics LLC, An Abbvie Company	1	$15
Menarini Silicon Biosystems, Inc.	1	$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,727 in reported general payments places this provider in the 95th percentile of 1,501 family providers in Nevada.

See all family providers in Nevada →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Ondansetron OdtOndansetron	137	$2,204
Dexamethasone	47	$937
Acyclovir	46	$762
Prochlorperazine Maleate	92	$578
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	21	$506
Lidocaine-PrilocaineLidocaine/Prilocaine	29	$353
Levothyroxine Sodium	37	$273
Prednisone	39	$189
Levofloxacin	12	$183
Tramadol Hcl	19	$168
Gabapentin	15	$108
Potassium Chloride	14	$77

Paid to pharmacies, not to this prescriber.

Other family in Reno

See the full list for Nevada →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →